Literature DB >> 15764154

Adhesion molecules as a prognostic marker of liver cirrhosis.

J A Girón-González1, C Martínez-Sierra, C Rodriguez-Ramos, P Rendón, M A Macías, C Fernández-Gutiérrez, F Díaz, L Martín-Herrera.   

Abstract

OBJECTIVE: Endothelial activation plays an active role in modifications of the circulatory status of cirrhotic patients. Soluble endothelial adhesion molecules, induced by pro-inflammatory cytokines, could be considered markers of endothelial activation. Their role in the natural history of cirrhosis and portal hypertension has not been reported. Our objective was to analyze the prognostic value of soluble adhesion molecules in cirrhotic patients.
MATERIAL AND METHODS: Serum concentrations of soluble CD14, soluble receptors of tumor necrosis factor alpha and adhesion molecules ICAM-1 (intercellular adhesion molecule-1) and VCAM-1 (vascular cell adhesion molecule 1) as well as mean blood pressure, plasma renin activity, aldosterone, vasopressin and norepinephrine concentrations were determined in 64 cirrhotic patients (Child-Pugh class: A 48.4%, B 34.4%, C 17.2%), without any evidence of infection, and in 25 healthy controls. Patients were followed-up for a mean of 36.4 (range 6-60) months.
RESULTS: Increased concentrations of soluble CD14, tumor necrosis factor receptors and ICAM-1 and VCAM-1 were detected in cirrhotic patients when compared with healthy controls. Tumor necrosis factor receptors and adhesion molecule concentrations were both significantly higher in advanced phases of cirrhosis (Child Pugh class C and B versus A). Fifteen patients died as a related consequence of liver cirrhosis. Multivariate analysis demonstrated that Child-Pugh score and serum levels of tumor necrosis factor receptor I and ICAM-1 were associated with mortality.
CONCLUSIONS: In addition to the classic factor implicated in mortality (Child-Pugh class), alterations in inflammation-related components and soluble adhesion molecules, as representatives of hemodynamic alterations, are of prognostic significance in cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15764154     DOI: 10.1080/00365520510011470

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  13 in total

1.  Selective Intestinal Decontamination in Portal Hypertension.

Authors:  William Kemp; Jaye Chin-Dusting
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

2.  Expression of beta2-integrin on leukocytes in liver cirrhosis.

Authors:  Anatol Panasiuk; Janusz Zak; Elzbieta Maciorkowska; Bozena Panasiuk; Danuta Prokopowicz
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 3.  Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.

Authors:  Mercedes Márquez; Clotilde Fernández Gutiérrez del Álamo; José Antonio Girón-González
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

4.  Effects of thalidomide on the expression of adhesion molecules in rat liver cirrhosis.

Authors:  Peng Lv; Shelley Chireyath Paul; Yanjv Xiao; Shiquan Liu; Hesheng Luo
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

5.  Bedside sublingual video imaging of microcirculation in assessing bacterial infection in cirrhosis.

Authors:  Muhammad Y Sheikh; Usman Javed; Jasjit Singh; Jayanta Choudhury; Omer Deen; Kulraj Dhah; Michael W Peterson
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

6.  Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients.

Authors:  Sara Corchado; Mercedes Márquez; Montserrat Montes de Oca; Paula Romero-Cores; Clotilde Fernández-Gutiérrez; José-Antonio Girón-González
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

7.  Monocyte adhesion molecules expression in patients with chronic hepatitis C liver disease.

Authors:  Nora E I El-Bassiouni; Ola M Mahmoud; Eman G El Ahwani; Raafat A Ibrahim; Azza E I El Bassiouny
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

8.  Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients.

Authors:  Sara Corchado; Luis F López-Cortés; Antonio Rivero-Juárez; Almudena Torres-Cornejo; Antonio Rivero; Mercedes Márquez-Coello; José-Antonio Girón-González
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

9.  Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome.

Authors:  Teresa Aldámiz-Echevarría; Juan Berenguer; Pilar Miralles; María A Jiménez-Sousa; Ana Carrero; Daniel Pineda-Tenor; Cristina Díez; Francisco Tejerina; Leire Pérez-Latorre; José M Bellón; Salvador Resino
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

10.  Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis.

Authors:  Cristina Solé; Elsa Solà; Manuel Morales-Ruiz; Guerau Fernàndez; Patricia Huelin; Isabel Graupera; Rebeca Moreira; Gloria de Prada; Xavier Ariza; Elisa Pose; Núria Fabrellas; Susana G Kalko; Wladimiro Jiménez; Pere Ginès
Journal:  Sci Rep       Date:  2016-08-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.